Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

4724 ARTÍCULOS , VIENDO DEL 3061 AL 3075

Characteristics and advantages of adeno-associated virus vector-mediated gene therapy for neurodegenerative diseases

Qu Y, Liu Y, Noor AF, Tran J, Li R.

Neural Regen Res. 2019 Jun;14(6):931-938. doi: 10.4103/1673-5374.250570.

Detection of axonal degeneration in a mouse model of Huntington's disease: comparison between diffusion tensor imaging and anomalous diffusion metrics

Gatto RG, Ye AQ, Colon-Perez L, Mareci TH, Lysakowski A, Price SD, Brady ST, Karaman M, Morfini G, Magin RL.

MAGMA. 2019 Aug;32(4):461-471. doi: 10.1007/s10334-019-00742-6. Epub 2019 Feb 15.

Huntington's Disease Clinical Trials Corner: January 2019

Rodrigues FB, Quinn L, Wild EJ.

J Huntingtons Dis. 2019;8(1):115-125. doi: 10.3233/JHD-190001.

Exercise in Huntington's Disease: Current State and Clinical Significance

Mueller SM, Petersen JA, Jung HH.

Tremor Other Hyperkinet Mov (N Y). 2019 Feb 4;9:601. doi: 10.7916/tm9j-f874. eCollection 2019.

Creating cell and animal models of human disease by genome editing using CRISPR/Cas9

Zarei A, Razban V, Hosseini SE, Tabei SMB.

J Gene Med. 2019 Apr;21(4):e3082. doi: 10.1002/jgm.3082. Epub 2019 Mar 15.

CRISPR-cas gene-editing as plausible treatment of neuromuscular and nucleotide-repeat-expansion diseases: A systematic review

Babačić H, Mehta A, Merkel O, Schoser B.

PLoS One. 2019 Feb 22;14(2):e0212198. doi: 10.1371/journal.pone.0212198. eCollection 2019.

Modulation of Enzyme Activity in the Kynurenine Pathway by Kynurenine Monooxygenase Inhibition

Phillips RS, Iradukunda EC, Hughes T, Bowen JP.

Front Mol Biosci. 2019 Feb 8;6:3. doi: 10.3389/fmolb.2019.00003. eCollection 2019.

Apathy Is Related to Cognitive Control and Striatum Volumes in Prodromal Huntington's Disease

Misiura MB, Ciarochi J, Vaidya J, Bockholt J, Johnson HJ, Calhoun VD, Paulsen JS, Turner JA; PREDICT-HD Investigators & Working Group.

J Int Neuropsychol Soc. 2019 May;25(5):462-469. doi: 10.1017/S1355617719000067. Epub 2019 Feb 26.

Fluid and imaging biomarkers for Huntington's disease

Zeun P, Scahill RI, Tabrizi SJ, Wild EJ.

Mol Cell Neurosci. 2019 Jun;97:67-80. doi: 10.1016/j.mcn.2019.02.004. Epub 2019 Feb 23.

Astrocytes in Neuropathologies Affecting the Frontal Cortex

Peteri UK, Niukkanen M, Castrén ML.

Front Cell Neurosci. 2019 Feb 12;13:44. doi: 10.3389/fncel.2019.00044. eCollection 2019.

Paliperidone Long-Acting Injections in Huntington's Disease for Motor and Behavioural Disturbances

van Oosterom N, Theodoros T.

Clin Drug Investig. 2019 Apr;39(4):407-410. doi: 10.1007/s40261-019-00759-8.

Niacin in the Central Nervous System: An Update of Biological Aspects and Clinical Applications

Gasperi V, Sibilano M, Savini I, Catani MV.

Int J Mol Sci. 2019 Feb 23;20(4):974. doi: 10.3390/ijms20040974.

MicroRNA in Brain pathology: Neurodegeneration the Other Side of the Brain Cancer

Godlewski J, Lenart J, Salinska E.

Noncoding RNA. 2019 Feb 23;5(1):20. doi: 10.3390/ncrna5010020.

Junctophilins emerge as novel therapeutic targets

Jiang J, Tang M, Huang Z, Chen L.

J Cell Physiol. 2019 Aug;234(10):16933-16943. doi: 10.1002/jcp.28405. Epub 2019 Mar 1.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias